Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer

NCT02396108 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel + Carboplatin + ASLAN001

Sponsor

National University Hospital, Singapore